News - Lansoprazole
ALLEGAN, Mich., May 18, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S.
DEERFIELD, Ill., May 2, 2012 /PRNewswire/ -- Celebrity chef Spike Mendelsohn knows all too well the effects of a busy and hectic lifestyle - especially for a person with acid reflux disease
Children without symptoms of gastroesophageal reflux whose asthma was being poorly controlled with anti-inflammatory treatment did not have an improvement in symptoms or lung function with the added treatment of the proton pump inhibitor lansoprazole, compared to patients who received placebo.
Adding the acid reflux drug lansoprazole to a standard inhaled steroid treatment for asthma does not improve asthma control in children who have no symptom of acid reflux.
